Abstract | OBJECTIVE: To focus on the optimal management of thromboembolic complication in patients who have undergone chemotherapy with concomitant brain metastases and referred to a Division of Clinical Oncology. BACKGROUND: CASE SUMMARIES: CONCLUSION:
|
Authors | Felice Vito Vitale, Stefano Rotondo, Edoardo Sessa, Giovanna Antonelli, Paolo Colina, Alessandra Parisi, Valentina Giamo, Francesco Ferraù |
Journal | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
(J Oncol Pharm Pract)
Vol. 17
Issue 2
Pg. 141-4
(Jun 2011)
ISSN: 1477-092X [Electronic] England |
PMID | 20015933
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Anticoagulants
- Nadroparin
|
Topics |
- Anticoagulants
(administration & dosage, therapeutic use)
- Breast Neoplasms
(physiopathology)
- Carcinoma, Non-Small-Cell Lung
(physiopathology, secondary)
- Cerebellar Neoplasms
(physiopathology, secondary)
- Dyspnea
(etiology)
- Female
- Humans
- Lung Neoplasms
(physiopathology)
- Male
- Middle Aged
- Nadroparin
(administration & dosage, therapeutic use)
- Pulmonary Embolism
(drug therapy, etiology, physiopathology)
- Severity of Illness Index
- Treatment Outcome
|